Table 4.

Factors Associated With Postvaccination Retention Among Vaccinated Participants, STRIVE (n = 7979)

RetainedUnivariableMultivariable
N (%)Odds Ratio (95% CI)Factor-Level
P Value
Odds Ratio (95% CI)Factor-Level
P Value
Randomization ArmCrossover Vaccination3628 (95.2)ref.0039
Immediate Vaccination4012 (96.5)1.4 (1.1–1.7)
GenderMale4748 (94.6)ref<.0001ref.0056
Female2892 (98.1) 3.0 (2.3–4.0)1.6 (1.2–2.3)
Age (tertiled) (years)18–272491 (93.8)ref<.0001ref<.0001
>27–352539 (96.3)1.7 (1.3–2.2)1.5 (1.2–1.9)
>352610 (97.6)2.6 (2.0–3.5)2.2 (1.7–3.0)
OccupationNursea2312 (99.0)ref<.0001ref<.0001
Doctor18 (90.0)0.1 (0.02–0.4)0.1 (0.02–0.5)
Pharmacist39 (100)>99.9 (<0.01 to >99.9)>99.9 (<0.01 to >99.9)
Allied health professionalb124 (95.4)0.2 (0.1–0.5)0.2 (0.1–0.5)
Community health worker145 (96.0)0.2 (0.1–0.6)0.3 (0.1–0.7)
Laboratory worker261 (97.0)0.3 (0.1–0.7)0.5 (0.2–1.1)
Frontline workerc3176 (94.3)0.2 (0.1–0.3)0.2 (0.2–0.4)
Surveillance worker393 (95.9)0.2 (0.1–0.4)0.4 (0.2–0.8)
Not currently workingd836 (93.6)0.2 (0.1–0.2)0.2 (0.1–0.4)
Other/Not reported336 (95.7)0.2 (0.1–0.4)0.3 (0.2–0.6)
Facility TypeClinic setting1536 (94.6)ref.0002
Ebola Facility2037 (96.2)1.4 (1.1–2.0)
Hospital2921 (96.9)1.8 (1.3–2.4)
Other/Not reported1146 (94.6)1.0 (0.7–1.4)
Enrollment SiteWestern Rural1655 (95.0)ref<.0001ref<.0001
Western Urban2783 (95.7)1.2 (0.9–1.6)0.8 (0.6–1.1)
Bombali1117 (98.2)3.0 (1.8–4.9)2.2 (1.3–3.6)
Tonkolili695 (98.9)4.6 (2.2–9.6)3.0 (1.5–6.3)
Port Loko (Port Loko Town)768 (93.4)0.8 (0.5–1.1)0.7 (0.5–1.0)
Port Loko (Lunsar)345 (94.4)1.0 (0.6–1.6)0.6 (0.3–1.0)
Port Loko (Kaffu Bullom)277 (95.5)1.1 (0.6–2.1)0.9 (0.5–1.6)
RetainedUnivariableMultivariable
N (%)Odds Ratio (95% CI)Factor-Level
P Value
Odds Ratio (95% CI)Factor-Level
P Value
Randomization ArmCrossover Vaccination3628 (95.2)ref.0039
Immediate Vaccination4012 (96.5)1.4 (1.1–1.7)
GenderMale4748 (94.6)ref<.0001ref.0056
Female2892 (98.1) 3.0 (2.3–4.0)1.6 (1.2–2.3)
Age (tertiled) (years)18–272491 (93.8)ref<.0001ref<.0001
>27–352539 (96.3)1.7 (1.3–2.2)1.5 (1.2–1.9)
>352610 (97.6)2.6 (2.0–3.5)2.2 (1.7–3.0)
OccupationNursea2312 (99.0)ref<.0001ref<.0001
Doctor18 (90.0)0.1 (0.02–0.4)0.1 (0.02–0.5)
Pharmacist39 (100)>99.9 (<0.01 to >99.9)>99.9 (<0.01 to >99.9)
Allied health professionalb124 (95.4)0.2 (0.1–0.5)0.2 (0.1–0.5)
Community health worker145 (96.0)0.2 (0.1–0.6)0.3 (0.1–0.7)
Laboratory worker261 (97.0)0.3 (0.1–0.7)0.5 (0.2–1.1)
Frontline workerc3176 (94.3)0.2 (0.1–0.3)0.2 (0.2–0.4)
Surveillance worker393 (95.9)0.2 (0.1–0.4)0.4 (0.2–0.8)
Not currently workingd836 (93.6)0.2 (0.1–0.2)0.2 (0.1–0.4)
Other/Not reported336 (95.7)0.2 (0.1–0.4)0.3 (0.2–0.6)
Facility TypeClinic setting1536 (94.6)ref.0002
Ebola Facility2037 (96.2)1.4 (1.1–2.0)
Hospital2921 (96.9)1.8 (1.3–2.4)
Other/Not reported1146 (94.6)1.0 (0.7–1.4)
Enrollment SiteWestern Rural1655 (95.0)ref<.0001ref<.0001
Western Urban2783 (95.7)1.2 (0.9–1.6)0.8 (0.6–1.1)
Bombali1117 (98.2)3.0 (1.8–4.9)2.2 (1.3–3.6)
Tonkolili695 (98.9)4.6 (2.2–9.6)3.0 (1.5–6.3)
Port Loko (Port Loko Town)768 (93.4)0.8 (0.5–1.1)0.7 (0.5–1.0)
Port Loko (Lunsar)345 (94.4)1.0 (0.6–1.6)0.6 (0.3–1.0)
Port Loko (Kaffu Bullom)277 (95.5)1.1 (0.6–2.1)0.9 (0.5–1.6)

Abbreviations: CI, confidence interval; ref, reference category; STRIVE, Sierra Leone Trial to Introduce a Vaccine Against Ebola.

aIncludes nurse, midwife, community health nurse, nursing aide, maternal-child health aide, nursing student, and vaccinator.

bIncludes pharmacist, dentist, medical counselor, nutritionist, and physiotherapist.

cIncludes contact tracers, ambulance crew, burial workers, cleaners, and swabbers (persons taking post mortem skin/mucosal swabs for Ebola testing).

dCurrent occupation information was updated for deferred crossover participants during the crossover period. Many were no longer working as the Ebola outbreak subsided, and Ebola response jobs ended. Crossover participants were offered vaccination regardless of work status.

Table 4.

Factors Associated With Postvaccination Retention Among Vaccinated Participants, STRIVE (n = 7979)

RetainedUnivariableMultivariable
N (%)Odds Ratio (95% CI)Factor-Level
P Value
Odds Ratio (95% CI)Factor-Level
P Value
Randomization ArmCrossover Vaccination3628 (95.2)ref.0039
Immediate Vaccination4012 (96.5)1.4 (1.1–1.7)
GenderMale4748 (94.6)ref<.0001ref.0056
Female2892 (98.1) 3.0 (2.3–4.0)1.6 (1.2–2.3)
Age (tertiled) (years)18–272491 (93.8)ref<.0001ref<.0001
>27–352539 (96.3)1.7 (1.3–2.2)1.5 (1.2–1.9)
>352610 (97.6)2.6 (2.0–3.5)2.2 (1.7–3.0)
OccupationNursea2312 (99.0)ref<.0001ref<.0001
Doctor18 (90.0)0.1 (0.02–0.4)0.1 (0.02–0.5)
Pharmacist39 (100)>99.9 (<0.01 to >99.9)>99.9 (<0.01 to >99.9)
Allied health professionalb124 (95.4)0.2 (0.1–0.5)0.2 (0.1–0.5)
Community health worker145 (96.0)0.2 (0.1–0.6)0.3 (0.1–0.7)
Laboratory worker261 (97.0)0.3 (0.1–0.7)0.5 (0.2–1.1)
Frontline workerc3176 (94.3)0.2 (0.1–0.3)0.2 (0.2–0.4)
Surveillance worker393 (95.9)0.2 (0.1–0.4)0.4 (0.2–0.8)
Not currently workingd836 (93.6)0.2 (0.1–0.2)0.2 (0.1–0.4)
Other/Not reported336 (95.7)0.2 (0.1–0.4)0.3 (0.2–0.6)
Facility TypeClinic setting1536 (94.6)ref.0002
Ebola Facility2037 (96.2)1.4 (1.1–2.0)
Hospital2921 (96.9)1.8 (1.3–2.4)
Other/Not reported1146 (94.6)1.0 (0.7–1.4)
Enrollment SiteWestern Rural1655 (95.0)ref<.0001ref<.0001
Western Urban2783 (95.7)1.2 (0.9–1.6)0.8 (0.6–1.1)
Bombali1117 (98.2)3.0 (1.8–4.9)2.2 (1.3–3.6)
Tonkolili695 (98.9)4.6 (2.2–9.6)3.0 (1.5–6.3)
Port Loko (Port Loko Town)768 (93.4)0.8 (0.5–1.1)0.7 (0.5–1.0)
Port Loko (Lunsar)345 (94.4)1.0 (0.6–1.6)0.6 (0.3–1.0)
Port Loko (Kaffu Bullom)277 (95.5)1.1 (0.6–2.1)0.9 (0.5–1.6)
RetainedUnivariableMultivariable
N (%)Odds Ratio (95% CI)Factor-Level
P Value
Odds Ratio (95% CI)Factor-Level
P Value
Randomization ArmCrossover Vaccination3628 (95.2)ref.0039
Immediate Vaccination4012 (96.5)1.4 (1.1–1.7)
GenderMale4748 (94.6)ref<.0001ref.0056
Female2892 (98.1) 3.0 (2.3–4.0)1.6 (1.2–2.3)
Age (tertiled) (years)18–272491 (93.8)ref<.0001ref<.0001
>27–352539 (96.3)1.7 (1.3–2.2)1.5 (1.2–1.9)
>352610 (97.6)2.6 (2.0–3.5)2.2 (1.7–3.0)
OccupationNursea2312 (99.0)ref<.0001ref<.0001
Doctor18 (90.0)0.1 (0.02–0.4)0.1 (0.02–0.5)
Pharmacist39 (100)>99.9 (<0.01 to >99.9)>99.9 (<0.01 to >99.9)
Allied health professionalb124 (95.4)0.2 (0.1–0.5)0.2 (0.1–0.5)
Community health worker145 (96.0)0.2 (0.1–0.6)0.3 (0.1–0.7)
Laboratory worker261 (97.0)0.3 (0.1–0.7)0.5 (0.2–1.1)
Frontline workerc3176 (94.3)0.2 (0.1–0.3)0.2 (0.2–0.4)
Surveillance worker393 (95.9)0.2 (0.1–0.4)0.4 (0.2–0.8)
Not currently workingd836 (93.6)0.2 (0.1–0.2)0.2 (0.1–0.4)
Other/Not reported336 (95.7)0.2 (0.1–0.4)0.3 (0.2–0.6)
Facility TypeClinic setting1536 (94.6)ref.0002
Ebola Facility2037 (96.2)1.4 (1.1–2.0)
Hospital2921 (96.9)1.8 (1.3–2.4)
Other/Not reported1146 (94.6)1.0 (0.7–1.4)
Enrollment SiteWestern Rural1655 (95.0)ref<.0001ref<.0001
Western Urban2783 (95.7)1.2 (0.9–1.6)0.8 (0.6–1.1)
Bombali1117 (98.2)3.0 (1.8–4.9)2.2 (1.3–3.6)
Tonkolili695 (98.9)4.6 (2.2–9.6)3.0 (1.5–6.3)
Port Loko (Port Loko Town)768 (93.4)0.8 (0.5–1.1)0.7 (0.5–1.0)
Port Loko (Lunsar)345 (94.4)1.0 (0.6–1.6)0.6 (0.3–1.0)
Port Loko (Kaffu Bullom)277 (95.5)1.1 (0.6–2.1)0.9 (0.5–1.6)

Abbreviations: CI, confidence interval; ref, reference category; STRIVE, Sierra Leone Trial to Introduce a Vaccine Against Ebola.

aIncludes nurse, midwife, community health nurse, nursing aide, maternal-child health aide, nursing student, and vaccinator.

bIncludes pharmacist, dentist, medical counselor, nutritionist, and physiotherapist.

cIncludes contact tracers, ambulance crew, burial workers, cleaners, and swabbers (persons taking post mortem skin/mucosal swabs for Ebola testing).

dCurrent occupation information was updated for deferred crossover participants during the crossover period. Many were no longer working as the Ebola outbreak subsided, and Ebola response jobs ended. Crossover participants were offered vaccination regardless of work status.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close